netrin-1 Activators
Netrin-1 activators are a category of chemical agents that engage with the signaling pathways of netrin-1, a multifunctional laminin-related protein. Netrin-1 is extensively studied for its role in axon guidance during neuronal development, where it operates as a guidance cue for directing the growth of nerve fibers. The protein interacts with specific receptors on the surfaces of cells to initiate a cascade of intracellular events that influence cellular behavior. These receptors include members of the DCC (Deleted in Colorectal Cancer) family and the UNC5 (Uncoordinated-5) family, among others. Netrin-1 activators aim to enhance the natural activity of netrin-1 by increasing its interaction with these receptors or by upregulating the signaling pathways downstream of receptor engagement. The modulation of netrin-1 activity is significant due to its involvement in the regulation of processes such as cell adhesion, migration, and survival, which are fundamental to the organization and maintenance of various tissues.
The chemical composition of netrin-1 activators is diverse, reflecting the complexity of the netrin-1 signaling pathways. These activators might be designed to mimic the structure of netrin-1 itself, thereby strengthening its interaction with its receptors. Alternatively, they could interact with other elements of the signal transduction pathways to enhance the response to netrin-1. For instance, an activator may stabilize the conformation of the netrin-1 receptor complex to prolong its active state or could interact with secondary messengers that propagate the signal within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride, an activator of GSK-3β, modulates the Wnt/β-catenin pathway. By inhibiting GSK-3β, it promotes the stabilization and accumulation of β-catenin, facilitating its translocation to the nucleus. This nuclear translocation enhances Wnt target gene expression, indirectly activating netrin-1 through the Wnt pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, a cyclic AMP (cAMP) activator, indirectly stimulates netrin-1 expression. Elevating cAMP levels activates PKA, which phosphorylates CREB. Phosphorylated CREB binds to the netrin-1 promoter, enhancing its transcription. This indirect activation through cAMP/PKA/CREB signaling elucidates a pathway by which forskolin can promote netrin-1 expression and activity. | ||||||
Lithocholic acid | 434-13-9 | sc-215262 sc-215262A | 10 g 25 g | $100.00 $272.00 | 1 | |
Lithocholic acid, an FXR agonist, indirectly activates netrin-1. Upon FXR activation, it forms a complex with RXR and binds to the FXR response element in the netrin-1 promoter, inducing transcription. This demonstrates an indirect mechanism through the FXR pathway by which lithocholic acid can stimulate netrin-1 expression, revealing a potential regulatory link between bile acids and netrin-1. | ||||||
Trolox | 53188-07-1 | sc-200810 sc-200810A sc-200810B sc-200810C sc-200810D | 500 mg 1 g 5 g 25 g 100 g | $38.00 $67.00 $235.00 $678.00 $1712.00 | 39 | |
Trolox, a water-soluble vitamin E analog, acts as an indirect activator of netrin-1. By suppressing oxidative stress, Trolox prevents ROS-mediated degradation of HIF-1α. Stabilized HIF-1α translocates to the nucleus, binding to the netrin-1 promoter and enhancing its transcription. This unveils a regulatory connection between oxidative stress, HIF-1α, and netrin-1 expression, implicating Trolox in modulating this axis. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPARγ agonist, indirectly activates netrin-1 expression. PPARγ activation forms a complex with RXR, binding to the PPAR response element in the netrin-1 promoter and enhancing transcription. Through this PPARγ-dependent mechanism, rosiglitazone demonstrates an indirect modulation of netrin-1 expression, linking the activation of PPARγ to the regulation of netrin-1 in cellular processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632, a ROCK inhibitor, indirectly activates netrin-1. Inhibiting ROCK reduces phosphorylation of LIMK, resulting in cofilin activation. Activated cofilin translocates to the nucleus and promotes netrin-1 transcription by binding to the promoter region. This uncovers a ROCK-dependent pathway through which Y-27632 indirectly activates netrin-1 expression, suggesting a potential link between ROCK inhibition and netrin-1 modulation. | ||||||
Amlexanox | 68302-57-8 | sc-217630 | 10 mg | $160.00 | 2 | |
Amlexanox, an IKKε/TBK1 inhibitor, indirectly activates netrin-1 through NF-κB modulation. By inhibiting IKKε/TBK1, Amlexanox hinders the phosphorylation of p65, preventing its nuclear translocation. This attenuation of NF-κB signaling results in enhanced netrin-1 transcription, highlighting a mechanism through which Amlexanox can exert indirect activation of netrin-1 by modulating the NF-κB pathway. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $79.00 $321.00 $671.00 | 1 | |
Indirubin-3'-monoxime, a GSK-3 inhibitor, indirectly activates netrin-1 expression. By inhibiting GSK-3, it stabilizes β-catenin, promoting its nuclear translocation. Nuclear β-catenin enhances netrin-1 transcription by interacting with its promoter. This reveals an indirect pathway through GSK-3 inhibition, demonstrating how indirubin-3'-monoxime can modulate netrin-1 expression by regulating the Wnt/β-catenin signaling cascade. | ||||||
GW 1929 | 196808-24-9 | sc-202640 | 1 mg | $91.00 | ||
GW1929, a PPARβ/δ agonist, indirectly activates netrin-1. PPARβ/δ activation forms a complex with RXR, binding to the PPAR response element in the netrin-1 promoter and enhancing transcription. Through this PPARβ/δ-dependent mechanism, GW1929 demonstrates an indirect modulation of netrin-1 expression, linking the activation of PPARβ/δ to the regulation of netrin-1 in cellular processes. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, an NF-κB inhibitor, indirectly activates netrin-1 by suppressing NF-κB signaling. Inhibition of NF-κB prevents the degradation of IκBα, inhibiting the nuclear translocation of p65. This attenuation of NF-κB activity enhances netrin-1 transcription, outlining a mechanism through which BAY 11-7082 can exert indirect activation of netrin-1 by modulating the NF-κB pathway. | ||||||